Marshall Wace
GYRE icon

Marshall Wace’s Gyre Therapeutics GYRE Stock Holding History

Marshall Wace’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,720
Closed -$128K – 2694
2024
Q2 		$128K Sell
10,720
-14,824
-58% -$203K ﹤0.01% 2378
2024
Q1 		$447K Buy
+25,544
New +$460K ﹤0.01% 1976
2022
Q1 		– Sell
-9,014
Closed -$61K – 3637
2021
Q4 		$61K Buy
+9,014
New +$154K ﹤0.01% 3514
2020
Q3 		– Sell
-1,874
Closed -$83K – 1720
2020
Q2 		$83K Buy
+1,874
New +$88K ﹤0.01% 1467
2020
Q1 		– Sell
-16,743
Closed -$855K – 1811
2019
Q4 		$855K Buy
+16,743
New +$702K 0.01% 1021
2019
Q2 		– Sell
-15,729
Closed -$957K – 1541
2019
Q1 		$957K Sell
15,729
-46,671
-75% -$3M 0.01% 943
2018
Q4 		$3.69M Sell
62,400
-10,745
-15% -$792K 0.04% 545
2018
Q3 		$5.91M Sell
73,145
-235
-0.3% -$18.6K 0.05% 423
2018
Q2 		$6.42M Buy
+73,380
New +$12.9M 0.1% 249

Other funds holding GYRE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AACP
Advantage Alpha Capital Partners San Francisco, California $332M AUM 12.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return